Full Report

Know the Business

MAB is a capital-light platform that earns a tax on every UK mortgage and protection policy its 2,100 advisers write — a network business dressed as a financial-services name. The economics are good in good times and surprisingly resilient in bad ones because market-share gains have offset cyclical volume declines, but the headline reported profit line is misleading: a data-feed quirk inflates "operating income" in the latest two years, and the real story is an adjusted PBT margin that has slipped from 12.0% to 11.4% even as revenue jumped 20%. The market is right that this is a quality compounder; it is mispricing the gap between the 2029 target margin (>15%) and the integration drag from the Fluent Money acquisition that sits in the way.

1. How This Business Actually Works

MAB rents out the regulated, technology-enabled wrapper around a mortgage adviser; advisers do the work, lenders and insurers pay the fees, MAB takes a slice off the top.

The revenue engine is one customer interaction monetised three times. An adviser sits with a homebuyer or remortgagor; MAB collects a procuration fee from the lender at completion (the largest stream, ~£106m in FY2024 per third-party disclosure), an insurance commission from the protection provider on any term-assurance, critical-illness or income-protection policy attached, and a small client-paid advice fee. Total revenue scaled to £319m in FY2025, on the back of just over £32bn of mortgages arranged and roughly 93,000 protection policies sold the prior year. The cash mechanics are unusually attractive: fees and commissions land centrally before being split with the adviser firm, which is why operating cash flow (£34m FY2025) tracks reported PBT (£22m) at over 150% — the working-capital cycle runs in MAB's favour.

There are two distinct chassis sitting under that revenue line and the difference matters more than any other operating distinction. The AR Network — about 200 Appointed Representative firms operating under MAB's FCA authorisation on five-to-ten-year contracts — is the asset-light original engine: MAB takes a share of revenue, the AR firm carries most of the variable cost. The Invested Businesses segment, dominated by the £50m+ Fluent Money acquisition in 2022, consolidates revenue and cost in full. That structural shift is the single reason the "gross margin" optical headline has compressed from 27% (FY2019) to 29% (FY2025) while looking flat — IB economics blend a higher revenue share against a higher cost-to-serve, so the platform is actually scaling beneath the consolidated number.

The cost base is mostly people and technology. Administrative expenses ran at 17.6% of revenue in FY2025 (up from 17.1%), with the increase entirely driven by IB integration. The proprietary technology stack — formerly MIDAS, rebranded "Hailo" in 2025 — is the durable asset: 25 years of customer-interaction data, lender API integrations and compliance tooling that an adviser would have to rebuild from scratch to leave. That is the moat. It is not network effects in the social-platform sense; it is the regulatory and operational switching cost of being an FCA-supervised mortgage adviser without MAB's plumbing.

2. The Playing Field

No public peer is a clean comp; together they triangulate where MAB sits, which is at the higher-quality end of UK adviser-platform economics with structurally lower margins than the pure-asset-management peers.

Read the chart by direction. Tatton Asset Management is the closest direct comp on business model — an adviser-support platform that takes a slice of AUM-linked revenue — and it sits where MAB's 2029 margin target wants to land, with 48% margins and 27% growth. The gap is not strategy; it is product mix. Tatton skims a fee on managed assets that earn 2-3% spreads; MAB skims a transactional fee on a £550bn UK mortgage market that compresses every refinancing cycle. Tatton's economics are simply better. TPFG is the platform-economics analogue from the property side — a franchise model that generates 29% PBT margins on £84m of revenue. It validates that "platform-as-tax" economics in UK financial services can sustain ~30% margins; MAB's 11% says either it has not finished consolidating IB earnings or the mortgage take rate is structurally lower. BRK is what bad capital allocation looks like at the same scale — wealth-management consolidator with declining revenue and 16% margin. OSB is in the table for completeness but is a different animal: it is a lender with a £4.4bn balance sheet, and the 58% pre-tax margin is net-interest-income economics, not platform fees. QLT and MNG are size anchors, not comps.

What "good" looks like in this peer set: 25-30% PBT margin, 10-15% organic revenue growth, ROE above 20%, and capex below 1% of revenue. MAB hits the last two and is materially short on the first. The 2029 target — >15% adjusted PBT margin while doubling revenue — would close half that gap.

3. Is This Business Cyclical?

Volumes are highly cyclical; MAB's revenue is much less so because market-share gains have offset every cyclical drawdown of the past decade.

The 2023 cost-of-living shock is the case study. UK gross mortgage lending fell from £315bn (2022) to £225bn (2023) — a 29% drop driven by the Truss mini-budget rate spike and subsequent demand destruction. MAB's revenue rose from £231m to £240m in the same year, because share went from 7.5% to 8.3% as smaller broker firms folded or lost adviser productivity faster than MAB's network. The same pattern shows in COVID (2020): UK lending fell 9%, MAB revenue grew 3%. This is not a coincidence; it is the recruiting flywheel. Downturns drive distressed adviser firms to seek the security of MAB's platform, and lender panel access becomes more valuable when product withdrawals are running at hourly cadence.

The cycle does still hit profit even when revenue holds. Adjusted PBT margin compressed from 14.7% (FY2019) to 6.7% (FY2023) before recovering to 11.4% (FY2025) — the IB cost base is largely fixed and refinancing-heavy revenue mix carries a lower take. The honest read: this is a counter-cyclical share-grabber, pro-cyclical margin business. Recovery years are where the real earnings leverage shows up; the FY2025 50% PBT growth on 19% revenue growth is an early read on FY2026-FY2028 if the Bank of England rate path normalises and refinance volume rebuilds.

4. The Metrics That Actually Matter

Five numbers tell you whether the platform is working. Everything else is either downstream of these or fluff.

Adviser productivity (£157k revenue per mainstream adviser, +13% YoY) is the lead indicator. It captures whether the technology investment is delivering operating leverage — productive advisers write more cases, attach more protection, and refinance their own back-book. A flat or declining productivity number against a rising market would mean the Hailo platform is not earning its keep.

Closing adviser count (2,135, +10% YoY) is the volume lever. After three flat years (2022-2024) of net hiring, 2025 marked the first material return to growth — and 65% of it came from existing AR firms expanding rather than new firms joining, which is the higher-quality cohort. Watch this number quarterly: an inflection here without productivity falling is the cleanest signal of operating leverage.

Market share — new lending (8.4%) and Product Transfers (3.0%) are the only externally validated competitive metrics. PT share grew from 2.7% to 3.0% in 2025; that gap (8.4% lending share against 3.0% PT share) is the structural opportunity. If MAB closes it through its mortgage-monitoring (Dashly) acquisition and dedicated retention advisers, it is several years of organic revenue growth without needing to recruit a single new adviser. The 2029 "double market share" target is essentially an expansion-to-PT bet.

Adjusted cash conversion (121%) measures the working-capital advantage. Above 100% is the platform tell — it means MAB collects revenue centrally before paying out the AR share. Falling below 100% would signal balance-sheet stress at the AR level or a working-capital deterioration in IBs.

Adjusted PBT margin (11.4%) is the bottom-line discipline check. The 2029 target is >15%; the current 60bp YoY compression (12.0% → 11.4%) is the hair on the story. The bridge is roughly: ~150bp of mix drag from IB integration, ~100bp of platform reinvestment that should reverse as Hailo capex normalises, and ~150bp of operating leverage from the next 50bp of share gains. If management hits 15% by 2029, this is materially undervalued. If margin sticks at 11-12%, it is fairly valued.

Conventional metrics like P/E and dividend yield mislead here because the headline net income is depressed by goodwill amortisation on Fluent Money (~£3.1m/yr of intangible amortisation flows through admin expenses) and adjusting items. Adjusted PBT divided by EV is the cleanest valuation anchor.

5. What Is This Business Worth?

This is best valued as one economic engine — a platform that earns a take-rate on a structurally large, low-growth, intermediated market, with margin expansion as the variable that determines whether the multiple rerates.

The right anchor is EV / adjusted PBT. At a £313m market cap, ~£21m of net cash and £6m of debt, EV is roughly £298m against £36m of adjusted PBT — call it 8.3x. That is below TAM (~16x) and TPFG (~14x), in line with BRK's depressed level, and well below where UK platform peers traded pre-2022. The discount is mostly explained by margin: TAM earns nearly five times MAB's PBT margin on the same revenue scale; close that gap by 350bp and the discount narrows mechanically.

The bull case mathematically works as: hit the 2029 target (revenue ~£640m at 15% adjusted PBT margin = ~£96m PBT), apply a 12-13x multiple consistent with TAM's current rating, and you're at roughly £1.1bn equity vs £313m today. The bear case is symmetric: margin sticks at 11%, IB integration drags another year, and the stock trades at ~7x PBT with no rerating. The variance between those two cases is bounded almost entirely by the adjusted PBT margin trajectory — not by interest rates, not by housing transaction volumes, not by FCA reform. That single line carries most of the risk-reward.

A sum-of-the-parts is not the right lens here despite the AR/IB structural distinction, because both engines monetise the same regulatory and technology stack — splitting them would double-count the moat. The exception worth flagging: if Fluent Money is ever spun out or sold, that £69m of goodwill plus £54m of intangibles reveals an acquisition that absorbs roughly 70% of total intangibles against only ~30% of revenue. An impairment test failure there is the only forensic flag in the valuation.

6. What I'd Tell a Young Analyst

Three anchors, in order of importance.

Build the revenue model from market share, not transaction count. UK mortgage volumes are forecast by UK Finance and IMLA; the right model multiplies expected new lending (£560-580bn for 2026) by MAB's share (8.4%, with 50bp/year of upside as the historical run-rate) by a £/£ revenue intensity (~£1 of MAB revenue per £100k arranged). Add the Product Transfer line at the same exercise (3.0% share of £261bn). That triangulates revenue within ±5% versus the consensus number that comes from rolling forward last year's figure. Anyone forecasting from a topline-growth assumption is missing the point — share is the variable that explains 70% of the growth gap to mortgage-market expectations.

The 50bp adjusted PBT margin compression in FY2025 is more important than the 50% PBT growth headline. Management framed FY2025 as a profit recovery year but margin actually went the wrong direction (12.0% → 11.4%) as IB integration cost pulled forward. The 2029 path requires a clear bend in this line by FY2026 — if the next set of results shows margin flat or down again, the 15% target loses credibility and the rerating thesis weakens. Watch the H1 2026 print closely: any read above 12% is the green light, below 11% is the red one.

The thesis-killer is not the rate cycle, not regulation, not Fluent. It is adviser productivity reversal. If average revenue per adviser goes from £157k back toward £140k while head count grows, the platform is not delivering operating leverage and the 2029 target is unreachable mechanically. That single number — disclosed semi-annually — is worth more than every page of the strategy presentation. Everything else (Main Market move, Hailo rebrand, Dashly acquisition, MAB 2.0 framing) is execution detail in service of that line.

The Fluent goodwill is worth keeping in the back pocket as a tail risk; a £104m intangibles balance against £76m of equity is a mathematical concern but not yet a forensic one — the IB segment is profitable and the original deal screen still pencils. The day to worry is when growth in the IB revenue line stalls before margin expands.

The Numbers

MAB is a small, cash-generative UK financial-distribution business with structurally high returns on equity (about 20%) and a 10y revenue CAGR near 17%, but the share price is two-thirds below its 2021 peak because reported pre-tax profit has been stuck around £22M for four years while the company spent £50M+ on acquiring Fluent Money in 2022. The headline that matters in the FY2025 results is adjusted pre-tax profit of £36M (+50% YoY) and 121% cash conversion — i.e., the underlying operating engine reaccelerated after a multi-year mortgage-market drought, but reported earnings still carry £8–14M of acquisition amortisation and exceptional drag. The single metric most likely to rerate or derate the stock is whether adjusted PBT margin recovers from 11.3% back toward the 12–15% band the company sustained pre-Fluent and explicitly targets by 2029.

A. Snapshot — what you're buying at 535.5p

MAB is the UK's largest mortgage intermediary network — about 2,135 advisers across roughly 200 Appointed Representative firms, arranging more than £32B of mortgages a year and holding 8.4% share of new UK mortgage lending. The business earns procuration fees from lenders (largest), protection commissions from insurers, and consolidates revenue from "Invested Businesses" — most importantly Fluent Money, acquired in 2022.

B. Quality scorecard — small, sticky, cash-generative

The quality picture is genuinely good on returns and cash conversion, but two flags need tracking: goodwill plus intangibles equal 163% of equity (a Fluent Money legacy — £70M goodwill, £54M intangibles), and the dividend is barely 1.2× covered by reported earnings, leaving little buffer if the housing cycle turns again.

C. Revenue and earnings power — 16-year view

Two stories live in these two charts. Revenue has compounded for sixteen years with only one mild dip (2020 Covid). But pre-tax margin has not recovered: 16% peak (FY2016) collapsed to 6.8% in FY2023 and is still only 6.9% on a reported basis in FY2025. That gap is partly Fluent Money's lower-margin specialist-lending mix being consolidated since 2022, and partly amortisation of acquisition intangibles (£8M+ a year). The company-reported adjusted PBT margin of 11.3% strips those out and is the truer operating-margin reading.

D. Half-yearly trend — the FY24/FY25 reacceleration

The half-year shape tells the cycle story cleanly. Revenue jumped in H2 FY2022 partly because Fluent Money was consolidated mid-year, then growth flatlined through FY2023 as the UK mortgage market collapsed under sharp BoE rate hikes. Both halves of FY2025 grew ~20% YoY — the strongest underlying half-yearly growth since the Fluent acquisition. Pre-tax pattern is noisier because acquisition amortisation and one-offs land unevenly between halves.

E. Cash flow — earnings convert to real cash

Operating cash flow has exceeded net income every year for a decade — the structural advantage of the network model is no inventory, minimal receivables risk, and procuration fees that settle quickly. FCF/NI has averaged 1.6× over the last 5 years (the spike vs reported NI is partly the £8M+ of non-cash amortisation flowing through net income post-Fluent). FY2025 FCF of £33.1M is the highest in MAB's history. Dividends paid (£12.8M) used 39% of FCF, leaving roughly £20M of unallocated cash even after the Fluent earn-out and small bolt-ons.

F. Capital allocation — Fluent dwarfs everything

The £50M Fluent Money cheque in FY2022 is the only thing on this chart that is not a dividend or a small bolt-on. Outside that single transaction, MAB's playbook for ten years has been a near-mechanical "earn it, pay most of it out". Cumulative dividends since the FY2014 IPO total roughly £135M versus cumulative M&A of about £85M (mostly Fluent-related) and capex of just £10M.

G. Balance sheet — small, intangible-heavy

Two facts to note. First, equity barely moved from £75M to £76M between FY2022 and FY2025 — three years of retained profit was largely matched by dividends, intangible amortisation, and a small FY2025 bolt-on (which lifted goodwill by £16M to £70M). Second, MAB went into FY2022 with £25M cash and £20M debt to fund the Fluent deal, and has steadily delevered: long-term debt is now £5.6M against £26.6M cash, leaving the firm with about £21M of net cash heading into FY2026.

H. Returns on capital — durable mid-teens / low-twenties

Pre-Fluent, MAB ran on a tiny equity base and reported ROE between 50% and 90% — a textbook capital-light network. The 2022 deal added £55M of intangibles and £55M of equity-like consideration, halving ROE structurally. The 18–21% range it has settled into since is still very good for a UK financial-services company; it just is no longer extraordinary.

I. Valuation — current vs its own history

The chart on the left is the valuation conversation in one image. P/E ranged 20–40× through 2014–2021 when MAB was a capital-light compounder; the multiple compressed to 22× during the 2022–2024 mortgage drought, and at 535.5p the stock now trades at roughly 20.8× trailing reported EPS and 8–9× trailing adjusted PBT. P/B has rebased from 15× pre-Fluent to about 4–5× because the equity base is now four times larger.

A 10.6% trailing FCF yield with a 4.1% dividend yield, on a balance sheet with £21M of net cash, is comfortably more attractive than the bare 21× P/E suggests. The FCF gap matters because amortisation of Fluent intangibles depresses GAAP earnings without affecting cash returns to the parent.

J. Peer comparison — the closest direct comp is Tatton

The honest answer is that there is no clean public comp for MAB. Tatton (TAM) is closest — a UK adviser-distribution platform with similar revenue-share economics and equally high ROE — but its discretionary fund management franchise commands a 28× P/E versus MAB's 21×. The true-direct comp Property Franchise Group screens cheaper (13.5× P/E) on better growth and similar margins; that is the gap MAB's CFO will be asked about every quarter. OSB and MNG are not really peers — they're balance-sheet financials whose multiples reflect different capital structures.

K. Fair value — bear / base / bull

The bear case is the cycle repeating — UK BoE rate cycle runs the wrong way, mortgage approvals soften again, advisers' productivity slips. The base case is mechanical: 12× a £42M adjusted PBT (12% margin × £350M revenue, both inside management's targets) gets you ~600p. The bull case requires the 2029 plan to land — double revenue and market share, adjusted PBT margin north of 15% — and a re-rating to the 15× the multiple compounders earn.

What the numbers say

The numbers confirm the structural quality of the network model — sixteen straight years of revenue compounding (15.5% 10y CAGR), 121% cash conversion, 20% ROE, an essentially ungeared balance sheet with £21M of net cash. They contradict the bearish "MAB is a small, cyclical, post-acquisition value-trap" framing — adjusted PBT just grew 50% YoY, both halves of FY2025 grew 20%, the dividend has been maintained through the worst UK mortgage market in a decade, and the £70M of goodwill has not impaired despite three years of pressure. The two things to watch into FY2026 results are: (1) whether adjusted PBT margin steps up toward 12% on the way to management's 15% 2029 target, and (2) whether the £100M+ goodwill-and-intangibles line stays clean — any Fluent-related impairment would be the single biggest negative surprise the company could produce.

Variant Perception — Where We Disagree With the Market

Where We Disagree With the Market

The market is pricing MAB as a structurally broken UK mortgage broker on a permanent margin reset, anchored to the post-Truss tape and the AIM-only liquidity profile — and the evidence says it is a counter-cyclical share gainer that just completed the Main Market migration on 30-Apr-2026 with mechanical FTSE inclusion ahead. Sell-side consensus carries a 1,150p target and Buy rating (Berenberg, March 2026), but the price sits 6% above the 506p 52-week low with a death cross still in force and Liontrust reducing its 17% stake — a clean disagreement between the analytical view and the market-implementation view. The variant perception lives in that gap: the market is treating the AIM-era ownership constraint as if it still binds, when in fact the structural cap was removed two days before this report. Three other smaller variant views — on the duration of margin compression, on capital-allocation revealed preference, and on the goodwill-impairment binary — sit alongside but do not change the core read.

Variant Perception Scorecard

The 72 score reflects a specific, observable, monetisable disagreement (the Main Market technical re-rating timeline) anchored in primary-source RNS evidence. The score is held back from the 80s because the bear's metric-architecture critique is also evidence-supported — the disagreement is about which side of a clean operational binary will print, not about whether the mechanism exists. Resolution arrives in two discrete events: FTSE quarterly review on 4-June-2026 and H1 FY26 interim results in September.

Consensus Map

The Disagreement Ledger

Disagreement #1 — the AIM-to-Main-Market ownership cap. Consensus would say the chart is bearish, the death cross is in force, and Liontrust at 17% reducing means the marginal flow is selling. Our evidence disagrees because the technical structure that generated those signals was exclusively a function of AIM-era ownership constraints — and those constraints came off on 30-Apr-2026 when the LSE Main Market readmission completed. The market would have to concede that ADV almost doubled (Q1 trading update +19% applications already fed into volume) and that the FTSE quarterly review on 4-June-2026 is now a hard mechanical event. The cleanest disconfirming signal is FTSE Russell deferring inclusion to the September review — that would mean the seasoning rule still binds and the variant is wrong by six months.

Disagreement #2 — capital allocation revealed preference. Consensus reads the rebased dividend (28.2p → 22.5p) and bolt-on M&A as bear flags. Our evidence disagrees because the £2.8m buyback at 8× adjusted PBT is the first material repurchase in MAB's listed history — buying back at a depressed multiple while statutory PBT is falling is rational EPS accretion, not optical engineering. The market would have to concede that EPS compounding through shrinking share count is a viable alternative to dividend-yield framing for a platform that converts cash at 121%. The disconfirming signal is no follow-on buyback announcement before Q3 2026 — that would mean the £2.8m was tactical rather than strategic.

Disagreement #3 — the margin trajectory is mechanical. Consensus reads the 60bps FY25 compression as a credibility flag against the 15% by 2029 target. Our evidence disagrees because the compression decomposes into three independently observable line items, each of which reverses on a known timeline. The market would have to concede that the next 50bps of market share comes mechanically from Product Transfer share (3.0% → 4.0%) at incremental margin, on top of the operating leverage already in the cost base. The disconfirming signal is H1 FY26 adjusted PBT margin printing flat or below 11.4% — that single data point would force estimate cuts and break the rerating.

Disagreement #4 — goodwill carry as cycle stress test passed. Consensus treats £124m unimpaired goodwill as a ticking binary. Our evidence disagrees because three years of cycle stress without a write-down is the auditor's economic test passing — Fluent's £4.4m FY24 PBT contribution against a £69m carry implies a 6.4% earnings yield and recoverable-amount cushion. The market would have to concede that the impairment risk has already been tested and rejected. The disconfirming signal is any FY26 audit Fluent KAM language in March 2027.

Evidence That Changes the Odds

How This Gets Resolved

What Would Make Us Wrong

The most credible disconfirming evidence sits in three discrete places. First, FTSE Russell could defer inclusion to the September review under the seasoning rule — the timing matters less than the signal. If MAB is admitted to FTSE Small Cap at 4-Jun-2026, the technical re-rating mechanism activates immediately; if deferred, the variant view becomes "right thesis, wrong timing" for six months and the bear's tape-driven case wins on a duration basis. The single observable that would close the gap is the FTSE Russell index changes notice typically published one week before the review effective date.

Second, H1 FY26 adjusted PBT margin printing below 11% with adviser productivity stalling below £150k would force consensus to mark down the FY27E margin assumption from 12.5% to 11.0%, which compresses the bull target from 800p to roughly 600p and validates the bear "metric architecture broken" framing. The variant view does not survive a structurally lower adjusted-PBT margin trajectory because the disagreement turns on the rerating mechanism reaching peer-group multiples — and the peer multiples (TAM at 28×, TPFG at 14×) are themselves underpinned by margin profiles MAB needs to be on a path toward.

Third, the most damaging single piece of evidence would be a partial Fluent CGU goodwill impairment at the FY26 audit (March 2027). That would not just reverse disagreement #4 but also amplify the bear's "metric architecture" critique — a £5m+ impairment is the auditor's confirmation that the adjusted-PBT framework has been masking economic pressure. The fragility of the variant view to this single binary is high; the probability of it occurring inside 12 months is moderate at best, but the consequence is structural.

The first thing to watch is the FTSE Russell index changes notice on or around 28-May-2026.

Bull and Bear

Bull and Bear

Verdict: Lean Long, Wait For Confirmation — the operational reacceleration is real and the Main Market catalyst has just landed, but the adjusted-vs-statutory wedge is real too and one bad H1 print breaks the rerating. The bull's strongest evidence is the share-grab through the worst UK mortgage cycle in 15 years (6.2% to 8.4% market share while gross lending fell 30%) paired with the catalyst that just triggered (LSE Main Market readmission on 30-Apr-2026 and a first-ever £2.8m buyback). The bear's strongest evidence is the £14.2m adjusted-to-statutory PBT gap that widened 56% YoY while the Remuneration Committee gates pay on the inflated number, against £124m of unimpaired goodwill and intangibles that equal 163% of equity. Both sides interpret the same FY25 print — adjusted PBT +13.3%, statutory PBT –3.4% — as evidence for opposite conclusions, and that is the tension that decides the stock.

Bull Case

Bull's price target is 800p in 12-18 months, derived from 14× FY27E adjusted PBT of ~£50m (£400m revenue × 12.5% margin, both inside management's 2029 envelope). Cross-checks at 5.5% FCF yield on a normalised £45m FCF run-rate. Primary catalyst: Q2 2026 LSE Main Market transition (just completed) plus FTSE quarterly review inclusion, paired with H1 FY26 interim results in September. Disconfirming signal: adviser count below 2,050 OR revenue per mainstream adviser below £150k in the H1 FY26 print — either single data point would say the platform is no longer earning operating leverage on Hailo.

Bear Case

Bear's downside target is 380p in 9-12 months, derived from 8× a normalised adjusted PBT of £30m (FY26E revenue £340m × 8.8% margin — the FY23 trough margin). Cross-checks at 14× reset basic statutory EPS of 27p = 378p. Primary trigger: a Fluent Money CGU goodwill impairment in FY26 results paired with FY26 adjusted PBT margin printing flat or below 11.4%. Cover signal: adjusted PBT margin above 12% in H1 FY26 alongside a clean goodwill impairment review and DPO retreating below 78 days.

The Real Debate

Verdict

Lean Long, Wait For Confirmation. The bull carries more weight because the operational data points are independently verifiable — 8.4% market share is a UK Finance number, +19% Q1 2026 applications is a primary-source RNS, the LSE Main Market readmission completed on 30-Apr-2026 is a hard fact, and £33.1m FCF is auditor-signed. The bear is right about the metric architecture — the adjusted-vs-statutory gap is unambiguously widening and the bonus structure does sit on the inflated line — but those are governance and accounting watchpoints, not mechanism-of-rerating concerns. The single most important tension is the margin trajectory: a 12%+ print in H1 FY26 makes the 2029 plan mechanical and the rerating to 14× FY27E adjusted PBT begins; a flat or sub-11% print confirms that the FY25 reacceleration was a comp-effect and the goodwill carry is exposed in the FY26 audit. The bear could still be right because £124m of unimpaired goodwill is real and the next downturn would test it brutally — and Liontrust's 17.04% reduction signals the largest holder is no longer a buyer. The condition that would change the verdict to a clean Lean Long is two consecutive halves of adjusted PBT margin above 12% on adviser productivity holding above £155k; the condition that would flip it to Avoid is any goodwill impairment paired with a profit warning before March 2027.

Catalysts — What Can Move the Stock

Catalyst Setup

The next six months hinge on a single observable variable: the H1 FY26 adjusted PBT margin print in September 2026. The hard catalyst — LSE Main Market readmission — already triggered on 30-Apr-2026, removing the AIM-only constraint that had capped the institutional bid for a decade; the next mechanical step is the FTSE quarterly review on 4-June-2026 (FTSE Small Cap inclusion window). The thinner end of the calendar is the back half of 2026, where the H1 print is the only event with real underwriting power. Every other 90-day item — the Q3 trading update, the AGM remuneration vote, the FY26 audit gateway — is supporting evidence rather than a thesis-changing event.

Ranked Catalyst Timeline

Impact Matrix

Next 90 Days

• 4-Jun-2026 — FTSE quarterly review. FTSE Russell decision on Small Cap / All-Share inclusion. Effective 22-Jun-2026 open. The matter beyond the headline: tracker AUM at the inclusion weight (likely 0.005-0.01% of FTSE All-Share) determines passive flow magnitude. PMs should monitor Index Solutions / FTSE Russell official notice on 28-May-2026.
• Mid-Jun-2026 — FY25 final dividend payment. 15.3p final dividend (ex-date 23-Apr-2026) pays mid-to-late June. Watch the post-pay-date tape; new Main Market dividend buyer behaviour is the unknown.
• Jul-2026 (TBC) — AGM and remuneration vote. First AGM under Audit Chair Mandy Donald and post-Main-Market listing. The matter beyond the headline: the advisory remuneration vote spread is the cleanest read on whether UK governance bodies are flagging the adjusted-vs-statutory gap. >10% against would amplify the bear case structurally.
• Aug-2026 — Q3 trading update. Application volume read on whether Q1 +19% YoY momentum holds. The matter beyond the headline: protection-attach rate vs mortgage applications — Q1 commentary did not give protection split.
• Continuous — FY26 buyback follow-on. No date but high probability before the September H1 print. Size and pace are the read.

What Would Change the View

The two observable signals that would most change the investment debate over the next six months are: (1) the H1 FY26 adjusted PBT margin print in September 2026 — anything from 12.0%+ shifts the verdict from "Lean Long, Wait For Confirmation" to "Lean Long" and supports the 800p bull target as mechanical; anything below 11% reverses the verdict toward Watchlist/Avoid and validates the bear's "metric architecture broken" framing; and (2) the size and pace of the post-Main-Market buyback programme — a follow-on programme above £15m alongside maintained dividend resolves the variant-perception view that management has shifted from yield to total-shareholder-return optimisation, while no buyback or further bolt-on M&A confirms the bear's "optical capital allocation" framing. The third lower-probability but very high-impact signal is any FY26 audit Fluent CGU KAM language (March 2027) — outside the 6-month window but worth flagging now because it is the single goodwill-impairment binary that would force a structural re-baseline of adjusted PBT.

The Full Story

In just over a decade as a public company MAB has gone from a £75m AIM debutant arranging £8bn of mortgages to a £319m revenue platform behind 8.4% of UK new mortgage lending — and along the way it has weathered the 2016 EU referendum, COVID, the 2022 Truss mini-budget, the worst UK mortgage downturn in a generation, and a £50m+ bet on Fluent Money that nearly all of its critics declared overpriced. The mission ("growth in market share, in all market conditions") has not changed in eleven years; what has changed is the model — from a pure Appointed Representative network paid a slice of procuration fees to a hybrid platform that consolidates "Invested Businesses", owns its own technology stack, and treats refinancing and protection as recurring-revenue engines rather than mortgage by-products. Through every cycle the founder-CEO has been the same person; through every cycle revenue has gone up; only profit margin has bent.

1. The Narrative Arc

The line above is remarkably linear from 2014 through 2022 — eleven years of compounding around 18% top-line CAGR. The shape changes in 2023, when revenue growth slowed to 4% and adjusted PBT fell 17%. Two things happened simultaneously: Fluent — bought a quarter before the worst macro shock to UK mortgages in fifteen years — swung from contributing to costing the Group £1.1m, and revenue per mainstream adviser collapsed as pipelines lengthened. The recovery in FY24 and FY25 has been broad-based and looks more like 2018 than 2023, but management has pointedly not declared the cycle over: the FY25 results explicitly note that 2026 lending growth depends on protection adoption and Product Transfer share, not on a sustained purchase-market recovery.

2. The Share Price Story

The price chart tells a sharper story than the financials. From IPO at 138p the stock compounded to 1,500p in August 2021 — a near-eleven-bagger in seven years driven by the post-COVID refinancing boom and the conviction that MAB would buy something transformational with its cash pile. It did, but the timing was unforgiving: Fluent completed in July 2022, the mini-budget hit in September, and the stock lost two-thirds of its value in fourteen months, bottoming at 482p in October 2022. The recovery from that low has been incomplete and choppy — three rallies above 800p (Dec-23, Jun-24, Jun-25) and three fades back into the 500–600p range — and at 535p on 1 May 2026 the shares trade roughly where they did in mid-2017, eight years and £125m of cumulative dividends ago. The market is paying for the recovery; it is not paying for the 2029 targets.

3. The IPO Era — FY2014 to FY2019

MAB came to market in November 2014 as a profitable, dividend-paying mortgage intermediary network with £56m of revenue and 1,457 advisers. It was a deliberate, slow-build first chapter: zero meaningful acquisitions through 2018, a steady drumbeat of organic adviser growth (+8% per year compound), and a payout ratio that never dipped below 70%. The numbers below are the cleanest in MAB's listed history — gross margin at 24%, adjusted PBT margin holding 12–14%, market share rising from 3.7% to 6.2%.

The single strategic move of the era arrived in July 2019, when MAB acquired 80% of First Mortgage Direct, the Aberdeen-based estate-agency-owned broker. It was a £14m equity outlay that introduced the "Invested Businesses" model — owning equity stakes in ARs and consolidating them rather than just collecting a network fee — and set the precedent for Fluent three years later. Revenue per active adviser averaged about £100k through this period; gross margin of 25%; ROCE consistently above 50%.

4. The COVID Bounce — FY2020 to FY2021

The April–May 2020 lockdown closed the UK property market completely. MAB cut 20% of staff pay, furloughed 101 advisers, and went into the H1 results with revenue actually +4%, helped by the First Mortgage consolidation. By December the housing market had reopened, the Stamp Duty holiday was in force, and the second-half rebound carried through 2021 into a refinancing boom of historic proportions: FY21 revenue +27% to £189m, adjusted PBT +36% to £24m, completions +33% to £22.8bn. The share price doubled twice — from a March 2020 low of 438p to August 2021's all-time high of 1,500p.

Two things to note. First, MAB never lost a half — adjusted PBT in H1 2020, the worst housing market in a generation, was higher than H1 2019. That number became the foundation of the "growth in all market conditions" claim that has dominated every results statement since. Second, FY2021 was atypical: a pulled-forward Stamp Duty holiday plus zero-rate mortgages produced revenue per adviser of £114k, the highest the company had ever recorded. Management framed it as a record, not a peak, and used the resulting cash flow to do something that would prove far more consequential than the pandemic itself.

5. The Fluent Bet — July 2022

On 12 July 2022, MAB closed the acquisition of The Fluent Money Group — a Bolton-based directly-authorised broker specialising in second-charge lending, bridging, later-life and remortgaging, with strategic partnerships into MoneySuperMarket and Compare the Market. The accounting cash outflow shows up as £50m in the FY22 acquisition line with deferred consideration carrying enterprise value to roughly £69m. It was the largest capital allocation event in MAB's history — equivalent to roughly half of the company's FY22 equity book and 3.5x trailing adjusted PBT for the target. Management's case was straightforward: Fluent gave MAB national, digital lead access — price-comparison sites, credit bureaus, property portals — that the AR network alone could never economically reach.

The early read on Fluent was the worst possible. Within ten weeks of completion the mini-budget froze the UK refinancing market, swap rates jumped 200bps, and Fluent — bought at the top of a strong-growth trajectory — swung to a £1.1m loss in 2023 against management's "significantly accretive in 2023" promise. Dignified language about "magnified impact" replaced the original transformation claims. By FY24 Fluent had recovered to £4.4m of adjusted PBT, contributing a £5.5m positive swing year-on-year, and by FY25 management was once again presenting Fluent as the engine of the refinancing strategy and the conduit to PCW lead sources. The acquisition is, on the FY24 numbers, paying back at roughly a 6.5% earnings yield — defensible but not the bargain the original deck implied. The ledger consequence is permanent: goodwill and acquired intangibles still represent ~70% of group equity, and the leverage taken on in 2022 only fully ran off by 2025.

6. The Cost-of-Living Shock — FY2022 to FY2023

The September 2022 mini-budget, the December 2022 BoE base rate rise to 3.5%, and the August 2023 peak of 5.25% combined to produce the worst UK new-mortgage market since the GFC. UK gross lending fell from £322bn in 2022 to £224bn in 2023 (-30%); MAB held revenue almost flat (£231m → £240m, +4%) while adjusted PBT compressed from £28m to £23m, the first decline in eleven years. The market read this as a structural problem rather than a cyclical one and the share price fell 64% peak-to-trough.

The disclosure record of the downturn is unusually clean. The H1 FY23 release, published 26 September 2023, cut adjusted PBT guidance to "not less than £22m" — a 35% reduction from the implied entry-year run-rate — and named the mini-budget by name as the trigger. The Q4 FY23 release blamed Fluent specifically rather than burying it. The July 2023 trading update referenced "extended completion timeframes" and the deteriorating purchase pipeline. Adviser numbers fell from 2,254 at year-end 2022 to 1,918 at year-end 2023 — the first net decline in a decade — and management said so plainly. What the company did NOT do was abandon a single strategic priority: the £105m of Fluent goodwill and intangibles was not impaired; the dividend was not cut; the technology investment continued. Three years later the through-cycle defence has held and market share grew from 6.2% to 8.4% across the worst purchase market in fifteen years — the single most quantitatively impressive number in MAB's listed history.

7. The Recovery — FY2024 to FY2025

The recovery is broad-based across every line. Revenue grew 11% then 20% — taking the total above the FY22 peak by FY25. Adjusted PBT rose 38% then 13% to a record £36m. Cash conversion stayed above 119% through the entire cycle, including 2023. Net debt fell from £16m to £3m. Mortgage completions hit £32bn for the first time in 2025 (+23%), well ahead of the 19% market growth, and the company crossed 8.4% market share in new lending and 3.0% in Product Transfers — the metrics that drive the whole 2029 plan. Adjusted PBT margin recovered most of the way back (12.0% in FY24, 11.4% in FY25) but has not returned to the 12.6% FY22 peak because of deliberately higher technology and protection investment, plus admin-cost reclassification from cost-of-revenue to admin in FY25 (which lifted gross margin and pushed admin ratio up).

8. The Current Chapter — 2026

The current chapter is the most concrete strategic plan MAB has had since IPO. The 2029 medium-term targets — set at the February 2024 Capital Markets Day and reaffirmed in March 2026 — are the first time management has publicly committed to a quantitative five-year envelope: double FY24 revenue (~£533m) and double market share (~17%), adjusted PBT margin above 15%, cash conversion above 100%. Everything about the FY25 results communication is calibrated to those numbers, not to single-year P&L. The platform rebrand from MIDAS to Hailo is presented as the technology underpinning customer reach. The Main Market move (Q2 2026, ESCC category) is positioned as broadening the investor base after returning £125m in cumulative dividends since IPO — more than the IPO market cap.

The leadership change is real but unalarmist. Ben Thompson stepped down as Deputy CEO on 31 December 2025 to take a strategic-projects role; Yaiza Luengo Morales joined as COO in January 2026. Founder Peter Brodnicki remains CEO into year twelve as a public-company chief executive — unusual durability for a UK PLC. CFO Emilie McCarthy, in post since 2024, signed her first full-year results.

9. What This History Tells You About the Next Five Years

Credibility score: 7.0 / 10. The reasons it isn't higher are specific and worth naming. Fluent was sold to investors as immediately accretive in 2023; it was loss-making in 2023 and only meaningfully accretive by 2024. Adjusted PBT margin guidance has been quietly walked from "12%+" through cycle to "15%+" by 2029 — a re-baselining that looks more aspirational than demonstrated. The reasons it isn't lower are also specific: market share has compounded through three macro shocks, every results statement has named the bad news in plain language (mini-budget, Fluent loss, adviser declines), the dividend has not been cut in eleven years, statutory PBT has never been negative, and management still uses the word "outperformance" only when the market data backs it.

What the price has historically rewarded: revenue growth above 15%, adjusted PBT margin holding above 12%, market share gains of 50bps or more per year, and dividend per share progression. From 138p in 2014 to 1,500p in 2021, every one of these was true continuously. What the price has historically punished: PBT margin compression below 11%, adviser-number declines, and Fluent-specific newsflow. The current chapter tests all four positive and one of the two negatives (margin sub-12%) at the same time.

What the reader should believe: market share progression (8.4% with a clear path to 9%+ on Product Transfer share alone), the structural attractiveness of the refinancing market (two-thirds of mortgage transactions, recurring), the resilience of the AR network through a downturn (2025 adviser numbers above the FY22 peak after a 15% trough). What the reader should discount: the optical neatness of the 2029 targets (half a decade of compounding into a target that requires either a strong macro or material new revenue streams). What the reader should watch: H1 FY26 revenue per mainstream adviser (the leading indicator of margin recovery), the trajectory of Fluent contribution into the £8–10m PBT range that justifies the 2022 deal, and the post-Main-Market institutional bid — a small-cap on AIM with a 4%+ yield trades quite differently in the FTSE 250 universe than in AIM-only mandates.

The story MAB tells about itself is unusually consistent for a 25-year-old founder-led business: customer reach, adviser productivity, technology, and selective M&A in service of those three. The story the price tells is more honest about the cost: outside of one extraordinary 2020–21 boom, the UK mortgage cycle dictates the rerating window, and the next one starts from somewhere around here.

Financial Shenanigans — Mortgage Advice Bureau (MAB1)

1. The Forensic Verdict

Risk grade: Watch (28/100). MAB's earnings quality is fundamentally good — high cash conversion (121% adjusted, 2.3x reported CFO/NI in FY2025), tiny capex (under 0.5% of revenue), no factoring, no supplier finance, no contract-asset build, BDO LLP as auditor with a clean opinion, and a simple platform model where revenue is mortgage-procuration fees, protection commissions and client fees collected centrally and remitted to AR firms. The two things to watch are not signs of manipulation but signs of accounting weight: (1) goodwill and acquired intangibles together total £123.6m — 163% of the £75.9m book equity, almost entirely the legacy of the 2022 Fluent Money deal, with no historic impairment to date; and (2) the gap between statutory PBT (£22.1m) and adjusted PBT (£36.3m) widened from £9.1m in FY2024 to £14.2m in FY2025, driven by a £5.1m step-up in acquisition-related amortisation, fair-value adjustments and put/call option accounting. The single data point most likely to change the grade is the next FY2026 goodwill/CGU impairment review under sustained pressure on UK mortgage volumes.

The CFO/NI ratio looks generous because MAB's working-capital float is structurally accretive: the Group collects procuration fees and insurance commissions centrally from lenders and insurers, then pays the AR firms their share. Trade payables grew from £39.5m (FY2024) to £50.6m (FY2025), a £11.1m source of operating cash on top of profit. That is a genuine economic feature of the platform — not an accrual gimmick — but investors who extrapolate 121% cash conversion past the next acquisition-integration year should haircut for the inverse working-capital release if AR growth ever slows.

Shenanigans scorecard

The scorecard registers four yellow flags and zero reds. The cluster — capitalisation discipline (#4, #9), acquisition-driven cash-flow effects (#10, #11), and the widening adjusted-versus-statutory gap (#12) — all trace back to the same root: MAB became an acquisitive platform in 2022 and the accounting tail of that decision is still unwinding. None of the items individually rises to a red flag.

2. Breeding Ground

Governance is a small-cap UK PLC norm with a founder-CEO holding modest equity, an independent BDO LLP audit relationship, and disclosed Audit Committee structure. Peter Brodnicki, founder and CEO since 2000, has not been replaced through 25 years of operation — long-tenured leadership creates oversight risk in principle but Brodnicki holds well under a 50% stake (no controlling-shareholder dynamic), draws a structured executive package, and the Audit Committee chair changed in June 2025 (Mandy Donald replacing Nathan Imlach, who is no longer considered independent given length of service). The Board added three independent NEDs in FY2025 (Paul Gill — compliance, Mandy Donald and Orlando Machado — IT/data) which is a strengthening signal. Deputy CEO Ben Thompson resigned in December 2025; CFO Emilie McCarthy is in post and the Group is preparing the move from AIM to the LSE Main Market.

Two breeding-ground items deserve underwriting. First, the heavy adjusted-metric culture: every management metric in the FY2025 financial review carries a footnote asterisk, and the headline narrative is built on Adjusted PBT (+13.3% to £36.3m) rather than statutory PBT (-3.4% to £22.1m). The APM framework is fully disclosed and reconciled, but the messaging hierarchy unambiguously favours the adjusted view. Second, the FY24 restatement that moved £4.9m of case-administration cost from admin expenses into cost of sales — gross-margin-neutral, profit-neutral, but it touches the comparability boundary that an attentive forensic reader watches. Neither item is a red flag.

The auditor relationship — BDO LLP, reappointment proposed at the FY26 AGM, no qualifications or emphasis-of-matter language disclosed in the FY2025 process — is the cleanest part of the breeding-ground picture. There is no insider-trading concentration, no late filing, no FCA enforcement against MAB Holdings (separate from the MAB-FCA-authorised operating entity, which is the regulatory perimeter for the AR Network).

3. Earnings Quality

Reported earnings look earned, with one architectural caveat that grows louder each year. Revenue grew 19.6% in FY2025 to £318.8m, driven by procuration fees up 27% and protection commissions up 12%. Gross margin held at 28.8% versus 28.9% prior; statutory PBT was essentially flat at £22.1m versus £22.9m. Adjusted PBT — the lead metric — grew 13.3% to £36.3m, a margin of 11.4% (down 60bps from 12.0%). The architectural caveat is that the £14.2m bridge between statutory and adjusted is now meaningfully larger than it was in FY2024 (£9.1m), and the adjustments are not "non-recurring" in any economically meaningful sense: amortisation of acquired intangibles will continue for the life of those intangibles, fair-value movements on put/call options on minority interests will recur as long as MAB owns those minority structures, and the bolt-on programme is itself a recurring strategy.

The chart shows two things. First, the gap is structural — it has been positive every year since the Fluent Money acquisition in 2022. Second, the gap as a percentage of statutory PBT was 39%, 43%, 40% and now 64% — meaning the adjustments now overwhelm the statutory measure. A reader who anchors on Adjusted PBT is anchoring on a number where almost two-thirds of the value would be excluded under straightforward IFRS. The disclosure is clean (the FY2025 financial review explicitly states "the adjustments between statutory and adjusted PBT relate entirely to acquisition-related costs"), but the directional trend warrants tracking.

Trade payables grew faster than revenue in FY2025 — 28% vs 20% — which is a genuine but bounded working-capital lifeline. The mechanism is straightforward: MAB receives commissions and procuration fees centrally from lenders and insurers, then distributes the AR firms' share. Higher activity at year-end (procuration fees +27% YoY) inflates the payable balance at the snapshot date. The £11.1m year-on-year payable build is real cash, but it is not repeatable in steady state once the activity-growth rate normalises. DPO rose from 76 to 81 days (payables / cost of sales × 365). This is the source of the "121% cash conversion" headline — a third of the over-100% conversion is timing.

SBC has ramped from £0.48m in FY2018 to £4.41m in FY2025 — a 9x increase against net income that is barely larger than seven years ago. SBC is fully expensed inside admin expenses and inside Adjusted PBT (it is not added back in the APM bridge), which is the conservative treatment and a positive on metric hygiene. But at 29% of net income and 1.4% of revenue, SBC is now a non-trivial dilution offset that deserves to be modelled explicitly rather than absorbed into headline EPS — diluted shares went from 52.2m (FY2018) to 58.5m (FY2025), a 12% increase across seven years.

Capitalisation discipline is clean by absolute scale — capex was £1.23m in FY2025 (0.4% of revenue), depreciation/amortisation was £10.7m, so D&A consistently exceeds capex by 8x or more. But the FY25 financial review notes "net £1.5m capitalised development cost, offset by associated amortisation" inside head-office admin, signalling that platform-related capitalisation does happen — small in absolute terms, worth tracking as the Platform ("Hailo") build-out continues. There were no impairments, no big-bath items, no restructuring charges in any year shown.

4. Cash Flow Quality

Reported cash flow looks better than reported earnings — and the gap is mostly real. FY2025 operating cash flow was £34.4m on net income of £15.1m, a 2.3x conversion ratio that would be a red flag at most companies. Here it is mostly explainable: D&A of £10.7m closes the largest gap, the £4.4m SBC add-back closes another, and the £11.1m payables increase closes a third — together £26m of the £19m gap is non-cash or working-capital release. The remaining cushion is genuine operating leverage on the platform.

The 7-year average CFO/NI is 1.79x and the most recent 3-year is 1.98x. There has not been a single year since FY2018 where reported CFO fell below net income, which is rare for a company of this size and is consistent with the underlying economics — MAB does not carry inventory, does not extend material credit, and does not own large receivables that age into delinquency.

FCF after acquisitions tells a more honest story than headline FCF for an acquisitive platform. Excluding the one large 2022 Fluent Money outlay (-£29.4m post-acq FCF), the trailing five years (FY2021, FY2023, FY2024, FY2025) show £21.6m, £21.2m, £27.4m, £27.3m of post-acquisition FCF — durable mid-£20m cash generation that supports the £12-16m annual dividend with comfortable cover. The bolt-on programme accelerated in FY2025 (£5.85m versus £2.25m FY24) as MAB acquired or topped up Heron, Evolve, Meridian, Lucra, Kinleigh and UK MoneyMan; total cash M&A consideration was £9.6m per management commentary, with the gap to the £5.85m cash-flow line reflecting deferred consideration and minority-interest payments rolling into investing activities differently.

There are no factoring, supplier-finance, securitisation, or receivable-sale disclosures. Net debt fell from £9.7m to £3.3m (0.1x leverage), the term loan was reduced by £2.3m net of RCF draw-downs, and unrestricted cash sits at £8.1m. This is a low-risk balance sheet with respect to liquidity-driven cash-flow tactics. The one watch-item is the deferred consideration build (FY25 financial review notes "additional deferred consideration payable in respect of recent acquisitions" inside non-current liabilities) — this is a hidden financing tail that converts into investing outflows over the next two to three years.

5. Metric Hygiene

The non-GAAP architecture is disclosed and stable but tilts the headline narrative materially in management's favour. MAB reports Adjusted PBT, Adjusted EBITDA, Adjusted Diluted EPS, Adjusted Cash Conversion, Free Cash Flow (defined as operating cash before strategic investment, M&A and dividends), Return on Capital Employed (using Adjusted EBIT), and Leverage (using Adjusted EBITDA). Every one is footnote-asterisked; there is a Glossary of APMs in the annual report; the bridges are reconciled. The forensic concern is not that the metrics are undefined — they are well defined — but that the gap between adjusted and statutory is now wide enough that a reader could form a meaningfully different view of the business depending on which lens they use.

The Adjusted EPS divergence is the most striking metric-hygiene observation. Adjusted Diluted EPS rose 13.5% in FY2025, while basic statutory EPS fell 5.8%. The 18.5p gap (44.5p adjusted minus 26.0p basic) corresponds to £12.5m of post-tax acquisition costs attributable to the parent — entirely the amortisation of acquired intangibles plus fair-value movements. Investors comparing year-on-year EPS growth across UK financials should be aware that MAB's adjusted-EPS growth materially overstates the underlying compounding of statutory bottom-line earnings.

The "Free Cash Flow" definition deserves a flag. MAB defines it as "operating cash flow before strategic investment, M&A and dividends" — closer to a cash-from-operations adjusted figure than the standard CFO-minus-capex industry definition. The £35.5m FY25 Free Cash Flow figure differs from the £33.1m simple CFO-minus-capex calculation by £2.4m, which reconciles to the strategic spend treatment of items like the £2.8m Dashly acquisition (treated as technology investment rather than M&A in the capital allocation framework). Both numbers are defensible in disclosure but a reader should not screen-compare MAB's "Free Cash Flow" against another platform's CFO-capex metric without reconciling.

6. What to Underwrite Next

The accounting risk here is a footnote, not a position-sizing limiter — but two specific items will determine whether the grade stays at Watch or drifts toward Elevated over the next twelve to twenty-four months. MAB's earnings quality fundamentals are good: simple platform model, no inventory, no factoring, no supplier finance, no securitisation, BDO clean opinion, low leverage, conservative SBC treatment, durable cash conversion, and no controlling-shareholder distortion. What is moving in the wrong direction is the architectural overhead from the bolt-on M&A programme: the goodwill/intangibles ratio to equity, the adjusted-versus-statutory PBT gap, and the deferred-consideration build that flows through investing rather than financing.

Track these five things in the next two reporting cycles:

1. FY2026 goodwill impairment review. Goodwill of £69.7m sits across the Fluent Money CGU and the FY2025 bolt-on cohort. A soft UK mortgage market (rate cycle, refi pull-forward exhaustion) would test the recoverable amount of the largest CGUs. Any partial impairment — even £5m — would be a meaningful signal because no impairment has ever been booked in MAB's history.
2. Adjusted-vs-statutory PBT gap. The gap moved from £9.1m to £14.2m in FY2025. If FY2026 widens the gap further (toward £18m+) on continued bolt-on intangible amortisation, the adjusted metric is structurally drifting from economic reality. If the gap narrows because MAB pauses the M&A programme, the underwriting case for Adjusted PBT improves.
3. Deferred consideration unwind. FY2025 non-current liabilities rose with deferred consideration on Heron, Evolve, Meridian, Lucra, Kinleigh and UK MoneyMan. These convert into investing outflows over FY2026-FY2028. The cumulative cash drag is the right way to read the FY2025 acquisition cohort, not the £5.85m headline cash-acquisition line.
4. Trade payables / DPO. DPO moved from 76 to 81 days in FY2025. If DPO retreats in FY2026 because activity growth normalises, the headline cash conversion will fall back toward 100-105% — still good but well below the 121% adjusted figure. This is a normalisation risk on the cash-conversion narrative, not an accounting problem.
5. SBC and dilution. SBC ramped from £2.55m (FY24) to £4.41m (FY25), back near the FY23 high of £4.43m. If SBC growth continues to outrun net income growth, the dilution offset is material; share count rose 0.9% in FY25 versus 1.0% in FY24. A buyback programme would be the cleanest offset.

Two signals would upgrade the grade toward Clean (sub-20): a clean BDO FY2026 opinion with no key-audit-matter language on goodwill, paired with a narrowing of the adjusted-versus-statutory gap. Three signals would downgrade it toward Elevated (above 40): a goodwill impairment (any size), a stopped or redefined non-GAAP metric, or evidence that deferred consideration on the FY25 bolt-on cohort is restructured to keep cash outflows out of the investing line. The FY26 print is the first full annualised year of the FY25 acquisition cohort and the first test of whether the bolt-on machine produces operating leverage faster than it produces accounting overhead.

The People

Governance grade: B+. Twenty-five years on, Peter Brodnicki is still running the company he founded — and that, more than any line in the remuneration report, is why this tab grades well. A long-tenured founder-CEO with a low-eight-figure personal stake, a small but technically credible board, and a recent step-change in NED quality (data, audit, M&A, regulatory) collectively justify the trust the equity story requires. What stops it being an A is concentration of execution on one man, a chief operating officer (Ben Thompson) who just stepped off the board after years as the visible #2, and a pension/bonus arrangement that until 2026 was still tilted in favour of the executive directors versus colleagues.

The People Running This Company

The board changed materially in 2025. The pre-2025 board was small, long-tenured, and tilted heavily towards Brodnicki's circle: Imlach had chaired Audit since 2014 (he stops being independent on time-served grounds in 2025 and is reclassified accordingly); David Preece retired; the executive bench was just CEO/CFO/Deputy CEO. The 2025 cohort — Paul Gill (CRO), Mandy Donald (Audit Chair) and Orlando Machado (data/AI NED) — is genuinely new blood, and the appointments line up tightly with what the company is asking shareholders to underwrite: a Main Market move (Donald), a Consumer-Duty/FCA-supervised intermediary at scale (Gill), and a "Hailo" platform whose pitch is data and AI (Machado). The criticism is that this depth arrived ten years after IPO, not at it.

The named succession question now sits on Yaiza Luengo. Bringing in an external COO in September 2025 and confirming her board appointment as the long-time Deputy CEO Thompson stepped off the Board on 31 December 2025 is the most material people event of the year. Brodnicki remains sole CEO. There is no public successor.

What They Get Paid

This is a textbook UK QCA-Code remuneration structure: cash salary, annual bonus, LSP performance shares, modest pension, plus a holding requirement that survives departure. The single line in the FY2025 governance report that matters here is the 2026 alignment of executive director pension contributions down to the 8%-of-salary colleague rate — i.e., MAB had an above-colleague executive pension differential, and the Remuneration Committee has now closed it. That is the right direction; the fact that it took until the year before a Main Market listing to do it is the small black mark.

The harder question is whether bonus and LSP are earned. Adjusted PBT — the bonus and LSP gating metric — is the same metric management chooses to headline (£36.3m FY25 vs £32.0m FY24, +13.3%) and which is above statutory PBT (£22.1m, –3.4% YoY). The gap is the £14.2m of "adjustments" added back, dominated by share-based payments, contingent consideration revaluations, and amortisation of acquired intangibles. Those adjustments are defensible in principle (Fluent goodwill amortisation is non-cash), but they make the metric the executive is paid on materially more flattering than the metric the auditor signs off. A reader who only takes one number from this section should take that one.

Are They Aligned?

This is the section where MAB scores well — the founder is still here, still owns shares, still calls strategy.

Ownership and the founder stake

The headline alignment fact is straightforward: at 535.5p, MAB1 has a market cap of ~£313m on 57.78m voting shares (58.02m issued, 240k in treasury). The founder is still CEO. He started the business in 2000, took it public in 2014, stayed on as CEO through the 2022 Fluent acquisition (a £50m+ bet that consumed multiple years of free cash and added £54m of goodwill), and through the 2025 platform rebrand to Hailo. That continuity is the alignment story — he eats the same outcome shareholders eat, on a larger plate.

The single share class is the right structural answer. There is no dual-class structure, no super-voting founder share, no pre-emption-busting permanent authority. The standing AGM authorities (allot up to two-thirds; disapply pre-emption up to 10%; buy back up to 10%) are the standard Investment Association guidelines and the directors explicitly state they have no present intention to use any of them. The buyback authority has been there for years; MAB has not used it — every pound of free cash has gone into dividends and selective M&A instead.

Insider activity

UK PDMR notifications via RNS are the equivalent of a US Form 4. The data feed for this run captured none for FY2025. That absence is itself a signal: a high-conviction founder with a material stake who is neither buying in the open market nor selling is, on balance, a hold. The dilution path is benign — share count has crept from 57.13m to 58.02m in two years (~1.6%), entirely through LSP/option satisfaction, well below the 10% / 5% Investment Association guidelines.

Capital allocation behaviour

Two things to flag here. First, the dividend was rebased lower in FY2025 to 22.5p (from 28.2p) — management has explicitly traded current yield for re-investment capacity, and the per-share dividend has effectively been redirected into a £12.4m M&A programme that bought up minority stakes in already-consolidated invested businesses. That is the right swap if those stakes earn back in adviser productivity gains; it is the wrong swap if Fluent's goodwill gets impaired (the goodwill plus intangibles together are ~70% of equity).

Second, the 2022 Fluent decision still defines this company's risk profile. £50m+ of cash out, £54m of goodwill in, and a mid-2020s mortgage downturn that immediately tested the thesis. Adjusted PBT margin compressed from 11.8% (FY22) to 9.7% (FY23) before recovering to 11.4% (FY25). The bet is not yet decisively earning out, but Fluent has "returned to a clear growth trajectory" in 2025 and specialist-lending client fees grew 28%. The CEO who made the call is the CEO who has to make it work — that is alignment in the form it should take.

Skin-in-the-game scorecard

Why 8/10: A founder-CEO at year 25 with the largest directors' stake, no dual-class shenanigans, no open-market selling, a clean dilution profile, and a board that has just been broadened with credible audit, risk and data NEDs. The two points lost are for the bonus-metric / statutory-PBT gap, the residual succession concentration, and the dividend rebase — each of which is defensible on its own but each of which biases the comp/cash-flow split in the executive's favour rather than the holder's.

Related parties

The 2025 corporate-action footprint includes multiple stake increases in Invested Businesses — Heron Financial, Evolve FS, Meridian, Vita Financial, UK MoneyMan, Kinleigh Financial Services. These are MAB's own AR partner firms, not third parties. Each transaction is disclosed; the sums are small (£0.2m–£2.1m); the put/call architecture (e.g., the Vita 25.5% with put-call structure; Fluent's committed acquisition of the remaining 36% in two tranches) is a known feature of the IB model. There is no disclosed self-dealing transaction with a director, no material related-party loan, and no conflict transaction in the 2025 governance report that requires recusal beyond ordinary IB consolidations.

Board Quality

Independence (excluding Chair, who is independent on appointment): four independent NEDs (Haworth, Donald, Machado, plus Jones as Chair) versus one non-independent NED (Imlach, on tenure grounds). With four executives on the Board (Brodnicki, McCarthy, Gill; Luengo subject to FCA approval), the Board is split four executives + four independents + Imlach + Chair, which is majority independent excluding the Chair but only just, and only after the 2025 changes.

The audit succession is handled correctly: Donald replaces Imlach as Audit Chair on her own arrival, Imlach loses independent status on time-served grounds and is correctly reclassified, and the Audit Committee picks up a sitting Chartered Accountant with multi-board experience. The risk seat is filled by an executive (Gill) reporting up through the Group Risk Committee and Audit Committee — UK-typical for a regulated intermediary.

The visible strengths are audit, M&A and data. The visible gaps are senior FS scale (no NED has run a £1bn-revenue UK FS business) and international experience (this is a domestic franchise, by design — but it limits external challenge on capital-allocation comparables).

The Verdict

The case for an A: Founder-CEO 25 years in, fully aligned, single share class, clean PDMR record, no buybacks ahead of share-price moves, no related-party self-dealing, modest dilution, dividend funded out of growing cash flow, and a 2025 board refresh that visibly upgrades audit, risk and data expertise just as the company shifts to the Main Market.

Why it stops at B+:

1. Bonus metric is "adjusted PBT", which is £36.3m versus statutory £22.1m. The £14.2m gap is mostly defensible (SBC, intangibles amortisation), but a Remuneration Committee that paid out on +13% adjusted growth in a year where statutory PBT fell 3.4% is gating on a metric that flatters management.
2. Succession is a single point of failure. Twenty-five years of one CEO is the alignment story; it is also the risk story. Thompson off the board on 31 December 2025 with no named replacement and a brand-new external COO whose board appointment still requires FCA approval is the year's most material governance event.
3. The Fluent overhang. £54m goodwill plus ~£51m intangibles together equal ~70% of book equity. The Board has now followed Fluent with a further £12.4m of M&A in 2025 and a rebased dividend to fund it. The strategic logic is sound; the impairment risk if a 2026 mortgage downturn hits is real and concentrated.

What would push this to A: a named CEO successor on the Board with credible runway; a year of clean Main Market governance with no comp policy votes against; and adjusted PBT and statutory PBT moving back into closer alignment as the Fluent intangibles amortise out. What would push this to C: a Fluent goodwill impairment, a forced CEO transition without a successor, or an FCA Consumer Duty enforcement action against the AR network.

Web Research — What the Internet Knows

The Bottom Line from the Web

Three recent events the filings cannot yet show: (1) MAB completed its move to the LSE Main Market on 30 April 2026 (RNS "Readmission" notice 1 hour before search-time on 1 May), removing the AIM-only constraint that has capped the institutional bid for a decade; (2) the company completed its first material share buyback (£2.8m) in late April 2026 — buyback authority has been on the books since IPO and unused until now, marking a structural shift in capital return; (3) the Q1 2026 trading update reports mortgage applications up 19% YoY in the first 16 weeks of 2026, validating the FY25 reacceleration thesis on volume — and confirming the consensus 1,150p price target (Berenberg, March 2026) is being underwritten on operational momentum the tape has not yet repriced.

What Matters Most

1. Main Market readmission completed 30 April 2026

The RNS-tagged "Readmission - Mortgage Advice Bureau (Hldgs) PLC" notice carried timestamp 30 April 2026; the company's prospectus had been approved a few days earlier. This is the catalyst the bull case has been pricing for two years — passive flow, FTSE inclusion windows, and broader long-only mandates open up. Status: confirmed, dated, primary-source RNS. Source: Investegate RNS feed (https://www.investegate.co.uk/announcement/rns/mortgage-advice-bureau-holdings—mab1/readmission-mortgage-advice-bureau-hldgs-plc/9548783); Investing.com 27-Apr-2026 confirmation (https://www.investing.com/news/company-news/mortgage-advice-bureau-moves-to-london-main-market-93CH-4638368).

2. First material buyback in MAB's listed history — £2.8m completed late April 2026

TipRanks, citing an MAB RNS update issued in the week to 24 April 2026, reports MAB completed a share buyback programme repurchasing shares totalling £2.8m and updated its voting rights accordingly. Until 2025 the buyback authority had stood since IPO with the explicit "no present intention" carve-out. The dividend was rebased lower in FY25 (28.2p → 22.5p) to fund M&A; the appearance of a material buyback alongside that rebased dividend signals management has shifted toward total-shareholder-return optimisation rather than dividend yield as the headline. Source: TipRanks (Apr 24-25, 2026 — "Mortgage Advice Bureau Completes £2.8m Share Buyback and Updates Voting Rights").

3. Q1 2026 operating momentum: applications +19% YoY in first 16 weeks

Per the late-April 2026 trading update referenced in the Investing.com Main Market story, mortgage applications were 19% higher in weeks 1–16 of 2026 versus the same period in 2025. This is roughly in line with the FY25 H2 revenue growth rate (also +19.6%) and confirms the thesis that the FY25 reacceleration was not a one-off comp effect but a structural recovery in transaction volume. Source: Investing.com (27-Apr-2026).

4. Sell-side consensus is 1,150p — more than 2× the current 535.5p price

Berenberg Bank reissued a Buy rating in March 2026; MarketBeat-aggregated consensus shows an average 12-month price target of 1,150p with a "Buy" consensus rating, against a market price now sitting 6% off the 506p 52-week low (Markets Daily, 30-Mar-2026). The gap between sell-side and tape is unusually wide for a UK small-cap with stable cash conversion. Source: Markets Daily / Berenberg coverage (https://www.marketbeat.com/stocks/LON/MAB1/).

5. Bolt-on machine continues: HomeOwners Alliance acquired April 2026 for £1.4m

Two weeks before the search, MAB acquired HomeOwners Alliance (HOA) from its founders and Smoove Limited in a £1.4m deal. HOA is a UK consumer property platform — strategically aligned with MAB's lead-generation/retention build-out under the Hailo platform. Adds incremental goodwill and intangibles to a balance sheet already loaded with £124m of acquired assets, but small enough not to move the impairment math. Source: East Midlands Business Link (Apr 17, 2026).

6. Insider buying — small but persistent open-market purchases

The People tab notes "no PDMR transactions captured" but the web shows two small open-market purchases inconsistent with that gap: Nathan Imlach (NED) bought 352 shares for £2,028 on 15-Apr-2026 and Ben Thompson (then Deputy CEO) bought 22 shares for £150 on 15-Sep-2025. Sizes are token — these are dividend-reinvestment-scale tickets — and signal alignment rather than conviction buying. The reclassified-non-independent NED buying after he stepped off the Audit Chair is a small positive governance signal. Sources: Markets Daily (https://www.marketsdaily.com), Ticker Report.

7. Liontrust holds 17.04% — single largest disclosed institutional stake

Liontrust Investment Partners LLP reduced its stake to 17.04% per a 2025 RNS-style notice on Investing.com. Liontrust is a UK-focused active manager; a 17% stake at an FTSE Small Cap candidate is materially concentrated. Reduction (rather than addition) is the directional read. The stock's ability to absorb selling pressure from this single holder is, by far, the most important liquidity question for any new institutional buyer.

8. Glassdoor sentiment is neutral — 3.9/5, 75% recommend

Across 114 reviews, MAB scores 3.9 out of 5 stars on Glassdoor with 75% recommending the firm to a friend; the Mortgage Manager sub-segment scores 4.2/5 across 16 reviews. This is mid-pack for UK financial services and offers no read-across to either the bull or bear case beyond "no obvious cultural breakdown." Source: Glassdoor.

Recent News Timeline

What the Specialists Asked

Insider Spotlight

The insider picture is consistent with the People tab: founder-led, no selling, two token NED/exec purchases. The most relevant single fact is what is not in the public record — no FY25 PDMR sale by any director.

Industry Context

The industry backdrop is the cleanest tailwind MAB has had since 2021. Web coverage repeatedly anchors on the +19% application growth as the lead read on FY26 — and the Main Market move adds a structural ownership-base widener that has nothing to do with operating performance.

Liquidity & Technicals — Mortgage Advice Bureau (MAB1)

MAB1 trades in pence on the London Stock Exchange and is capacity-constrained for institutional buyers: an ADV of roughly 461k shares clears about £1.2m of value per session at 10% participation, so a 1% issuer-level position takes ~7 trading days to exit. The tape is bearish on a 3–6 month view — price sits 21.5% below the 200-day SMA, a death cross fired on 2025-09-19, and a 12-month string of lower highs has now broken the 506p 52-week low intraday in late March 2026 before recovering. The only pieces of constructive evidence are a positive MACD histogram cross in mid-April and an oversold RSI bounce off ~21 in mid-March; both still need to clear the 50-day SMA at 578p to matter.

A. Implementation verdict — first-screen strip

B. Price snapshot

The shares are within 6% of the 52-week low (506p, set on 2026-03-27) and have shed more than a third of their value over the past year. A beta of ~1.0 understates real-economy sensitivity: this is a UK consumer-credit franchise, and mortgage volumes are themselves the cyclical variable.

C. The critical chart — 11+ years of price with 50/200 SMA

Price is below the 200-day SMA — current 535.5p vs 200d 682.5p, a 21.5% deficit. The full-cycle picture is brutally honest: a slow grind from the 2014 IPO at 152p to a ~625p plateau pre-COVID, a moonshot to 1,500p in August 2021 on the post-pandemic mortgage boom, then a -65% peak-to-trough collapse into late-2022 as rate rises gutted UK mortgage volumes. The 2024 rally to 916p (Jul-2024) failed to break through the 950p resistance from mid-2022, and the chart has been carving lower highs since. This is a downtrend.

D. Moving averages — full alignment

The alignment is perfectly bearish: price < 20d < 50d < 100d < 200d, with each successive MA further above price. The 200-day at 682p is now a multi-month resistance zone; even a 25%+ rally from here would only reach the rolling fair-value mid-range. Until the 50-day at 578p flattens and the 20-day at 562p rolls upward through it, no setup exists for trend buyers.

E. Cross history — three death crosses in two years

Six 50/200 crosses in 36 months means MAs are whipsawing — neither side has held trend long enough for a position trader to compound. That alone is a tell about UK small-cap mortgage names in this regime: low conviction, high reactivity to rate-path news.

F. Momentum panel — RSI and MACD over 18 months

RSI registered an oversold print of 21.9 in mid-March 2026 — rare in this name (last comparable touch was September 2025 at 27). The bounce off that low was real but partial: RSI recovered to 51 in late April before sliding back to 41 today. MACD histogram briefly turned positive 7-Apr through 20-Apr as the spring bounce played out, then flipped back negative on 27-Apr. Combined: short-term momentum is fading after a corrective rally, not building. The most recent oversold extreme produced a 30p tactical move, not a sustained bottom.

G. Volume profile and ADV

Volume has stepped up materially since mid-March 2026 as the stock broke to new 52-week lows. Weekly averages are running 3–6× the late-2025 baseline of ~80–120k/day. This is the classic signature of forced selling — likely fund redemptions or a fundamental holder exiting given the FY25 earnings disappointment. It is not the volume signature of a clean bottom.

The 30-Mar-2026 spike (5.3M shares, 18.7× normal) is the most significant institutional-scale event in the recent tape. It coincided with a single-day +6.7% pop, suggesting a block was crossed near the 52-week low at 506p — a buyer, not a seller. That is an interesting tell for the watchlist case (real institutional money showed up at the lows) but on its own does not establish a bottom.

H. Volatility — running hot

Realized 30-day vol is 45.5% — above the 10-year median (40%) and approaching the p80 stress band (51%). This is materially elevated for a UK financial-services name and roughly 50% above where the same metric stood through summer 2025 (28–35% range). The volatility expansion that began with the September 2025 sell-off has held — confirming a regime change rather than a one-off shock. ATR(14) at ~16.5p means the average daily range is now roughly 3% of price, expensive for any cost-sensitive execution.

I. Institutional liquidity panel

A. ADV and turnover

ADV20 sits 21% above ADV60, which means recent activity has been heavier than the trailing two-month baseline — driven entirely by the late-March/April capitulation volume. Annual turnover of 84% is healthy for a UK small-cap and shows the stock is not "stuck" with deep insider holdings; the float does change hands. Daily-value of £2.6m, however, is a hard ceiling on institutional access — five funds doing £200k each in one session would already represent 40% of total volume.

B. Fund-capacity table — what AUM can hold what weight

Read this table left-to-right for the quickest answer to "can my fund act here?" A £100m portfolio running a 5% weight (£5m position) needs ~10 days to build at 20% ADV — manageable but not trivial. A £500m fund at 5% (£25m position) is at capacity even at 20% participation. Smaller specialist funds (sub-£25m) can move with no friction at all.

C. Liquidation runway — how many days to exit

A 1% issuer-level position needs a fortnight to liquidate at conservative (10%) participation. That is the practical ceiling for institutional ownership. Anything chunkier requires either a block trade through a market-maker or a tape that has multi-week patience. Note that Peter Brodnicki and other insiders hold a meaningful slug, so true free-float liquidity is materially lower than the headline £313m market cap implies.

D. Execution friction

The 60-day median daily range is 2.07% of the close — above the 2% threshold that flags elevated impact cost. Combined with realized vol at 45%, the practical cost of a hurried entry or exit is meaningful: even a 0.5% position requires patience or you pay the bid-ask in slippage. Zero zero-volume days in the last 60 sessions, which is reassuring.

Bottom line on liquidity: the largest issuer-level position that clears within five days at 20% ADV is 0.5% of market cap (~£1.6m). At 10% participation, the same size needs 7 days. Funds above ~£100m AUM should treat this as a 2–4 week build/exit name, not a same-week trade.

J. Support, resistance and actionable levels

The only actionable levels in the next quarter are 506p below and 578p above. Below 506p, the chart vacates to 472p with nothing in between — that's the line in the sand for any stop-loss. Above 578p (the 50-day SMA), the next test is the 200-day at 682p — getting there would require a 28% rally and is not the central case in the next 90 days. The realistic 3-month range to plan around is 480p–600p.

K. Technical scorecard

Net score: -4 out of -6 to +6. Five of six dimensions score zero or negative. The one neutral (relative strength) is forced by the absence of benchmark data, not by genuine outperformance — absolute return of -37% over 12 months in a flat-to-up UK market is a clear underperformance signal that would normally take this row to -1 as well.

L. Stance — bearish on 3-to-6 month horizon

The technical setup is bearish. Price has lost the 200-day, posted a third death cross of the cycle, broken below the 52-week low intraday, and is doing so on rising volume and elevated volatility — every one of the four dimensions of the chart is saying the same thing. The mid-March RSI(21) oversold print and the late-April MACD-histogram positive cross gave bulls a tactical bounce of ~30p but neither has held, and the failure pattern matches every prior bear-trend rally in this name (Q4-2024, Q3-2025).

Two specific levels would change the view:

• Above 578p (50-day SMA) — a weekly close above this on rising volume reopens 640–680p as a target and would be the first sign the death cross is being neutralized.
• Below 506p (52-week low) — a weekly close below 506p activates 472p as the next support and confirms an extension of the 18-month downtrend; that is also the level at which the dividend yield approaches 5%, which may serve as a soft floor for income buyers.

Liquidity is a constraint for any fund running £100m+ AUM at 5% position weights, but it is not the bottleneck for the smaller specialist UK small-cap mandates that are the natural buyers here. The correct action right now is watchlist — wait for either a weekly close above 578p with volume confirmation or a capitulation low and bullish reversal candle below 506p that prints on 2× ADV and is not given back the next day. Building a position here, in the middle of a confirmed downtrend, has poor reward-to-risk regardless of fundamental conviction.

M. Disconfirming signals to monitor

The strongest case the bears could be wrong runs through three things: the 30-March block trade was real institutional accumulation, the BoE rate cycle pivots faster than priced, and the Main Market transition triggers passive demand. The price action does not yet reflect any of those, but they are the things to watch.

---

Technicals derived from 2,894 daily OHLCV observations (Nov-2014 through May-2026) and pre-computed indicators in data/tech/. All prices in pence (GBp); 100p = £1. ADV calculations use 20-day trailing window through 2026-05-01.